Announcements Trials
Browse Landscape

Phase

Phase 2 71Phase 3 11Phase NA 7Phase 1/2 5Phase 4 2Phase 2/3 2Phase 1 1

Status

Unknown 4Recruiting 1

Sponsor Class

OTHER 5INDUSTRY 3

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 4Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 2Triple Negative Breast Neoplasms 1HER-2 Positive Colorectal Cancer 1Breast Cancer Metastatic 1Brain Neoplasms 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 154Carboplatin 146Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 118Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × pyrotinib × Clear all
NCT06718933 2025-02-06

Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis

Fudan University

Phase 1/2 Recruiting
74 enrolled
Breast

Breast Cancer Metastatic

NCT03772353 2023-03-07

PLEASURABLE

Fudan University

Phase 1/2 Unknown
59 enrolled
Breast

Breast Neoplasms

NCT04582968 2023-01-18

Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases

Fudan University

Phase 1/2 Unknown
39 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT03805399 2022-08-10

FUTURE

Fudan University

Phase 1/2 Unknown
140 enrolled
Breast

Triple Negative Breast Neoplasms

NCT04227041 2020-01-14

A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer

Qingdao Zhixin Health Technology Co., Ltd.

Phase 1/2 Unknown
34 enrolled
Gastrointestinal

HER-2 Positive Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡